Carillon Tower Advisers' Q2 2024 investor letter discusses the market performance and highlights AstraZeneca PLC (NASDAQ:AZN) as a promising stock pick. The letter emphasizes the potential of AI stocks for higher returns and provides insights on hedge fund portfolios.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing